Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Iodobenzenes
Veterans
The ketogenic diet revisited: back to the future.
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet. 2012 May; 44(5):575-80.
View in:
PubMed
subject areas
Cells, Cultured
Dystroglycans
Fibroblasts
Genetic Complementation Test
Glycosylation
Humans
Infant
Laminin
Mannose
Mannosyltransferases
Mutation
Nucleotidyltransferases
Polysaccharides
Skin
Walker-Warburg Syndrome
authors with profiles
William B. Dobyns